Umasudhan Palaniswamy

Leading Beaconpoint Labs, a purpose-built laboratory for food and supplement testing that promises fearless transparency through a collaborative client experience and deliver fast, reliable results. Driven by a conviction that the industry deserves better, we are committed to transforming the laboratory space with advanced technology, uncompromising pursuit of scientific excellence, and true collaborative partnership with our customers.

Full P&L leadership of a science-based nutraceutical ingredient company, transforming the business into a fully integrated manufacturer and branded ingredient platform serving human and companion animal health markets. Key accomplishments: Transformed the company from a commodity ingredient supplier into a differentiated branded ingredient and condition-specific solutions provider, improving margins, pricing power, and customer value proposition. Restored sustained profitability by repositioning the portfolio toward higher-value product platforms and disciplined commercial execution. Expanded B2B business by strengthening key customer relationships and building a customer-centric commercial organization focused on branded ingredient platforms. Implemented CRM-driven sales management (HubSpot) and key account processes to improve pipeline visibility, customer engagement, and commercial discipline. Built strategic growth platforms in men’s health, hair wellness, joint health, healthy aging, and plant-based nutrition. Strengthened manufacturing and supply chain capabilities, improving efficiency, scalability, and long-term raw material stability. Led product innovation and intellectual property strategy, creating patented and clinically supported ingredient platforms with strong competitive differentiation. Developed licensing and royalty-based partnerships with leading supplement brands to build higher-margin, recurring revenue streams. Founded and launched Flomentum®, a direct-to-consumer men’s health brand, and successfully divested the business with ongoing royalty and supply agreement. Built and aligned cross-functional teams across sales, marketing, science, manufacturing, and operations to support long-term growth and enterprise value creation. Worked closely with the Board on strategic planning, financial performance, and long-term value creation.

Founded and launched Flomentum®, a direct-to-consumer men’s health brand built on Valensa’s core ingredient platform; positioned as a premium, science-based prostate health brand supported by medical marketing and digital DTC strategy. Built medical credibility through urologist engagement while driving consumer acquisition through performance marketing, resulting in strong retention, high customer lifetime value (CLV), and efficient ROAS. Successfully divested the DTC brand in 2023 to refocus on B2B growth, while securing a long-term licensing and supply agreement with the new ownership.

Led transition to new leadership structure and aligned the organization with long-term growth strategy. Developed and initiated execution of a 5-year strategic plan focused on vertical integration, branded ingredient manufacturing, and sustainable profitability. Rationalized product portfolio to prioritize high-margin, scalable platforms aligned with core strategic focus. Strengthened operational and financial discipline by improving manufacturing efficiency, maximizing capacity utilization, and exiting non-performing assets to support long-term growth.

Developed and executed sales and marketing strategy to support corporate growth goals across ingredient business and condition-specific formulations. Built a customer-focused sales organization and expanded customer base across multiple channels including mass market, natural products, practitioner, DTC, MLM, and international markets. Strengthened brand recognition for key product platforms including USplus®, Parry Organic Spirulina, Zanthin® Natural Astaxanthin, plant-based Omega-3, and value-added formulations. Launched condition-specific formulations and value-added products through strategic marketing partnerships and channel expansion. Managed joint venture activities and supported integration of partnerships and acquisitions aligned with long-term business strategy.

Introduced Valensa investment opportunity to EID Parry and supported strategic partnership that led to EID Parry acquiring an initial stake in US Nutraceuticals / Valensa International. Transitioned to Valensa to strengthen Sales & Marketing and support integration of Valensa nutraceutical operations. Played a key role in aligning the combined nutraceutical ingredients business and supporting subsequent full acquisition of Valensa by EID Parry.

Founding team member in building Parry Nutraceuticals, developing OTC, retail, and nutraceutical ingredient businesses across domestic and international markets. Built distributor network and sales organization to expand presence in retail, pharmacy, and health product channels. Led global expansion of Organic Spirulina and natural carotenoid ingredients through partnerships with leading supplement and pharmaceutical companies across 30+ countries. Helped position the business for strategic expansion through acquisition by EID Parry, supporting growth of the nutraceutical division.

Business Management, Sales and distribution strategy, Supply chain management, International finance, Marketing across cultures and Business Strategy.